ECO Animal Health Group (LON:EAH) Announces Quarterly Earnings Results

ECO Animal Health Group (LON:EAH) announced its quarterly earnings data on Monday. The company reported GBX 2.49 ($0.03) earnings per share for the quarter, Digital Look Earnings reports. ECO Animal Health Group had a net margin of 1.17% and a return on equity of 1.27%.

ECO Animal Health Group Price Performance

ECO Animal Health Group stock opened at GBX 75 ($1.00) on Wednesday. ECO Animal Health Group has a 52 week low of GBX 50 ($0.67) and a 52 week high of GBX 122.25 ($1.64). The company has a quick ratio of 2.14, a current ratio of 2.96 and a debt-to-equity ratio of 4.81. The stock has a market cap of £50.82 million, a price-to-earnings ratio of 48.48 and a beta of -0.05. The business has a 50-day simple moving average of GBX 61.57 and a 200 day simple moving average of GBX 60.65.

Insider Activity

In related news, insider David Hallas bought 29,962 shares of the company’s stock in a transaction that occurred on Friday, April 25th. The stock was bought at an average cost of GBX 67 ($0.90) per share, for a total transaction of £20,074.54 ($26,877.15). Insiders own 21.65% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Shore Capital reiterated a “buy” rating and issued a GBX 150 ($2.01) price objective on shares of ECO Animal Health Group in a research note on Monday.

ECO Animal Health Group Company Profile

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.